glp 1 drugs in development GLP-1 Market Industry Trends and Global Forecasts 2024-2035: Over 150 GLP-1 Drug Candidates for Multiple Indications, Type 2 Diabetes and Obesity Drive GLP-1 Drug Development Boom Discovery of GLP-1–Based Drugs for

GLP-1 stands for 'glucagon-like peptide-1.' It's a natural hormone your body produces in your gut after you eat

Conclusion The GLP-1 revolution is one of those rare moments in medicine when a class of drugs reshapes clinical expectations

stated behavior

The LEAN trial (Liraglutide Efficacy and Action in NASH) was a landmark study published in The Lancet (2016) demonstrating that liraglutide 1.8 mg daily led to NASH resolution in 39% of patients compared to 9% in the placebo group after 48 weeks

Regionally, Asia-Pacific Led the GLP-1 Market

However, he cautioned that its still important to follow the guidelines set by the American Society of Anesthesiologists, and there may be times when the procedure needs to be delayed if too much food is still in the stomach (5)